Canopus BioPharma Incorporated

CBIA · OTC
Analyze with AI
8/31/2022
8/31/2021
6/30/2014
6/30/2013
Operating Activities
Net Income-$1-$0-$1-$1
Dep. & Amort.$0$0-$0-$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$0$0-$0-$0
Other Non-Cash$1$0$3$0
Operating Cash Flow-$0-$0$2-$1
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0$0-$2$0
Investing Cash Flow$0$0-$2$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash$0-$0$0-$0
Supplemental Information
Beg. Cash-$0$0$0$0
End Cash$0-$0$0-$0
Free Cash Flow-$0-$0$2-$1